StrokeAQoLStrokeNCT07668245
Effectiveness of Attention Focus Training on Attention and Quality of Life in Stroke
A study testing Exercise and Conventional in people with Stroke, run by Shifa Tameer-e-Millat University at 1 site in Pakistan.
Trial summary
This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Read more about this study
- Who is it for?
- Ages Up to 55 years
- Conditions the study is for
- Stroke
- What is being tested?
- Exercise and Conventional
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Aug 2026to Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 55 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Participants diagnosed with stroke
- Able to ambulate at least with assistance
- Medically stable
Who cannot join
- Severe cognitive impairment (MMSE < 24)
- Pre-existing dementia
- Visual/hearing impairment
Trial locations and contacts
1 site in 1 country.
About this study
This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Intervention will be provided for 4 weeks. Outcomes will be assessed at baseline and after provision of intervention.
- Conditions
- Stroke
- Being tested
- Exercise, Conventional
- Keywords
- Attention, Quality of life, Stroke
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseOther
Focused attention (auditory target detection), Sustained attention (letter cancellation), Selective attention (cancellation with distractors), Alternating attention (number-letter switching)
ConventionalOther
Positioning and bed mobility, sitting balance training, standing training
| Study group | Role | What they receive |
|---|---|---|
| Attention Focus Training with Conventional therapy | Experimental | The training group will address the four core components of attention: focus, sustained, selective and alternating attention. Additionally, conventional therapy for stroke will be given. Receives: Other: Exercise; Other: Conventional |
| Conventional therapy | Active comparator | Conventional therapy for stroke will be given Receives: Other: Conventional |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stroop Color-Word Test
It consists of three conditions/sheets: (i) Word (W), in which the participant reads color words; (ii) Color (C), in which they name the ink colors; (iii) Color-Word (CW), in which they name the ink color while inhibiting the tendency to read the conflicting word. Responses are recorded and calculated for all three sheets. Scores are based on the number of correct responses within the specified time (45 minutes), with higher scores indicating better performance.
Measured: Baseline and post 4 weeks of intervention
Trail Making Test Test (A & B)
Trial Making Test (TMT) consists of two parts (TMT-A \& TMT-B). For TMT-A, participants connect numbers in sequential order (e.g. 1-2-3-4). For TMT-B, participants alternate between numbers and letters (e.g. 1-A-2-B-3-C). Participants are instructed to completed each task as quickly and accurately as possible. Score is primarily the time in seconds to complete the task. Lower time denotes better performance.
Measured: Baseline & post 4 weeks of intervention
Stroke Impact Scale
Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke.
Measured: Baseline and post 4 weeks of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2026
- Study start1 Aug 2026
- Primary completion15 Sep 2026
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 46 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Shifa Tameer-e-Millat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shafaq Altaf, Shifa Tameer-e-Millat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07668245
- Sponsor's protocol ID
- 026-26
- Acronym
- AQoLStroke
- Status last verified
- Oct 2026
- First submitted
- 19 Jun 2026
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Attention Focus Training on Attention and Quality of Life in Stroke
- ClinicalTrials.gov ID
- NCT07668245
- Acronym / sponsor ID
- AQoLStroke / 026-26
- Conditions
- Stroke
- Keywords
- Attention, Quality of life, Stroke
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 46 participants (estimated)
- Lead sponsor
- Shifa Tameer-e-Millat UniversityUniversity, hospital or other
- Study start
- 1 Aug 2026 (actual)
- Primary completion
- 15 Sep 2026 (actual)
- Study completion
- Oct 2026 (estimated)
- First posted
- 25 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Intervention will be provided for 4 weeks. Outcomes will be assessed at baseline and after provision of intervention.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Attention Focus Training with Conventional therapy | Experimental | Other: Exercise, Other: ConventionalThe training group will address the four core components of attention: focus, sustained, selective and alternating attention. Additionally, conventional therapy for stroke will be given. |
| Conventional therapy | Active comparator | Other: ConventionalConventional therapy for stroke will be given |
Who may qualify
- Ages
- Up to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Participants diagnosed with stroke
- Able to ambulate at least with assistance
- Medically stable
Key exclusion criteria (3 listed)
- Severe cognitive impairment (MMSE < 24)
- Pre-existing dementia
- Visual/hearing impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExerciseFocused attention (auditory target detection), Sustained attention (letter cancellation), Selective attention (cancellation with distractors), Alternating attention (number-letter switching) | Other | Attention Focus Training with Conventional therapy |
| ConventionalPositioning and bed mobility, sitting balance training, standing training | Other | Attention Focus Training with Conventional therapy, Conventional therapy |
Primary outcome
Stroop Color-Word Test
Time frame: Baseline and post 4 weeks of intervention
It consists of three conditions/sheets: (i) Word (W), in which the participant reads color words; (ii) Color (C), in which they name the ink colors; (iii) Color-Word (CW), in which they name the ink color while inhibiting the tendency to read the conflicting word. Responses are recorded and calculated for all three sheets. Scores are based on the number of correct responses within the specified time (45 minutes), with higher scores indicating better performance.
Trail Making Test Test (A & B)
Time frame: Baseline & post 4 weeks of intervention
Trial Making Test (TMT) consists of two parts (TMT-A \& TMT-B). For TMT-A, participants connect numbers in sequential order (e.g. 1-2-3-4). For TMT-B, participants alternate between numbers and letters (e.g. 1-A-2-B-3-C). Participants are instructed to completed each task as quickly and accurately as possible. Score is primarily the time in seconds to complete the task. Lower time denotes better performance.
Stroke Impact Scale
Time frame: Baseline and post 4 weeks of intervention
Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise and Conventional in people with Stroke, run by Shifa Tameer-e-Millat University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stroop Color-Word Test (time frame: Baseline and post 4 weeks of intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.